Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is the Skeletal System?01:02

What is the Skeletal System?

45.7K
Overview
45.7K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Bone Disorders01:29

Bone Disorders

8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

671
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
671
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

762
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
762
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

End-stage renal failure.

Postgraduate medicine·2016
Same author

Effects of oral rehydration and external cooling on physiology, perception, and performance in hot, dry climates.

Scandinavian journal of medicine & science in sports·2012
Same author

Mechanomyographic responses of the superficial quadriceps femoris muscles to incremental isometric muscle actions.

Electromyography and clinical neurophysiology·2008
Same author

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.

Clinical nephrology·2008
Same author

Comparison of Fourier and wavelet transform procedures for examining mechanomyographic and electromyographic frequency versus isokinetic torque relationships.

Electromyography and clinical neurophysiology·2005
Same author

The acute effects of static stretching on peak torque, mean power output, electromyography, and mechanomyography.

European journal of applied physiology·2004

Related Experiment Video

Updated: May 4, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

87.9K

Aluminum and renal osteodystrophy.

H G Nebeker, J W Coburn

    Annual Review of Medicine
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Aluminum accumulation in chronic renal failure patients causes bone disease. Chelation therapy with desferrioxamine shows promising results in improving patient symptoms and bone health.

    More Related Videos

    Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
    08:53

    Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

    Published on: January 1, 2017

    8.8K
    Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
    07:45

    Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

    Published on: February 9, 2021

    2.9K

    Related Experiment Videos

    Last Updated: May 4, 2026

    Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
    07:17

    Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

    Published on: April 14, 2016

    87.9K
    Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
    08:53

    Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

    Published on: January 1, 2017

    8.8K
    Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
    07:45

    Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

    Published on: February 9, 2021

    2.9K

    Area of Science:

    • Nephrology
    • Bone Metabolism
    • Toxicology

    Background:

    • Aluminum accumulation is a recognized complication in patients with chronic renal failure.
    • This accumulation has been linked to specific bone pathologies, including osteomalacia and aplastic bone lesions.
    • Sources of aluminum exposure include dialysate solutions and aluminum-containing phosphate binders.

    Purpose of the Study:

    • To investigate the role of aluminum in renal osteodystrophy.
    • To evaluate the efficacy of desferrioxamine chelation therapy in removing aluminum and improving bone health in affected patients.

    Main Methods:

    • Review of epidemiological data, chemical bone aluminum measurements, and histological analyses.
    • Utilizing animal models for aluminum loading studies.
    • Clinical assessment of patients undergoing long-term desferrioxamine chelation therapy during dialysis.

    Main Results:

    • Evidence supports a causal link between aluminum accumulation and renal osteodystrophy.
    • Desferrioxamine effectively increases ultrafilterable plasma aluminum, facilitating aluminum removal.
    • Patients treated with desferrioxamine demonstrated significant clinical and histological improvements.

    Conclusions:

    • Aluminum accumulation is a significant contributor to renal osteodystrophy in chronic renal failure.
    • Desferrioxamine chelation therapy offers a viable treatment option for aluminum toxicity.
    • Preventive strategies include reducing aluminum in dialysate and developing alternative phosphate binders.